JPWO2021038023A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021038023A5 JPWO2021038023A5 JP2022513412A JP2022513412A JPWO2021038023A5 JP WO2021038023 A5 JPWO2021038023 A5 JP WO2021038023A5 JP 2022513412 A JP2022513412 A JP 2022513412A JP 2022513412 A JP2022513412 A JP 2022513412A JP WO2021038023 A5 JPWO2021038023 A5 JP WO2021038023A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- antibody
- sequence shown
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1912437.9 | 2019-08-30 | ||
| GBGB1912437.9A GB201912437D0 (en) | 2019-08-30 | 2019-08-30 | CR2 Binding Proteins and their use in Medical Therapy |
| PCT/EP2020/074049 WO2021038023A1 (en) | 2019-08-30 | 2020-08-28 | Cr2 binding proteins and their use in medical therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022545947A JP2022545947A (ja) | 2022-11-01 |
| JPWO2021038023A5 true JPWO2021038023A5 (ko) | 2023-08-31 |
Family
ID=68207176
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022513412A Pending JP2022545947A (ja) | 2019-08-30 | 2020-08-28 | Ｃｒ２結合タンパク質および医学的治療におけるそれらの使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230032643A1 (ko) |
| EP (1) | EP4021938A1 (ko) |
| JP (1) | JP2022545947A (ko) |
| KR (1) | KR20220053000A (ko) |
| CN (1) | CN114375305A (ko) |
| AR (1) | AR119865A1 (ko) |
| AU (1) | AU2020338807A1 (ko) |
| BR (1) | BR112022003623A2 (ko) |
| CA (1) | CA3151687A1 (ko) |
| GB (1) | GB201912437D0 (ko) |
| IL (1) | IL290649A (ko) |
| MX (1) | MX2022002478A (ko) |
| WO (1) | WO2021038023A1 (ko) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3883899T3 (de) | 1987-03-18 | 1999-04-22 | Sb2, Inc., Danville, Calif. | Geänderte antikörper. |
| EP1001021B1 (en) * | 1998-09-25 | 2003-08-27 | Wolfgang Prodinger | Monoclonal antibody to human CD21, and its uses |
| IL127127A0 (en) | 1998-11-18 | 1999-09-22 | Peptor Ltd | Small functional units of antibody heavy chain variable regions |
| US20050089932A1 (en) | 2001-04-26 | 2005-04-28 | Avidia Research Institute | Novel proteins with targeted binding |
| US20050053973A1 (en) | 2001-04-26 | 2005-03-10 | Avidia Research Institute | Novel proteins with targeted binding |
| CN100594037C (zh) * | 2002-11-15 | 2010-03-17 | Musc研究发展基金会 | 通过补体受体2定向的补体调节剂 |
| CA2543360A1 (en) | 2003-10-24 | 2005-05-06 | Joost A. Kolkman | Ldl receptor class a and egf domain monomers and multimers |
| PT2506871T (pt) | 2009-11-30 | 2016-11-07 | Janssen Biotech Inc | Mutantes de fc de anticorpos com funções efetoras inutilizadas |
| JP5986990B2 (ja) * | 2010-05-14 | 2016-09-06 | ザ リージェンツ オブ ザ ユニヴァーシティ オブ コロラド，ア ボディ コーポレート | 改善された補体レセプター２（ｃｒ２）ターゲティング基 |
| JP2018521004A (ja) * | 2015-05-18 | 2018-08-02 | ユーリカ セラピューティックス， インコーポレイテッド | 抗ｒｏｒ１キメラ抗原受容体 |
| US11214603B2 (en) * | 2016-04-27 | 2022-01-04 | The Regents Of The University Of Michigan | C3D cellular and acellular vaccines for the prevention and treatment of cancer |
-
2019
- 2019-08-30 GB GBGB1912437.9A patent/GB201912437D0/en not_active Ceased
-
2020
- 2020-08-28 MX MX2022002478A patent/MX2022002478A/es unknown
- 2020-08-28 JP JP2022513412A patent/JP2022545947A/ja active Pending
- 2020-08-28 EP EP20767985.3A patent/EP4021938A1/en active Pending
- 2020-08-28 CA CA3151687A patent/CA3151687A1/en active Pending
- 2020-08-28 AU AU2020338807A patent/AU2020338807A1/en active Pending
- 2020-08-28 KR KR1020227010200A patent/KR20220053000A/ko active Search and Examination
- 2020-08-28 WO PCT/EP2020/074049 patent/WO2021038023A1/en unknown
- 2020-08-28 BR BR112022003623A patent/BR112022003623A2/pt unknown
- 2020-08-28 AR ARP200102433A patent/AR119865A1/es unknown
- 2020-08-28 US US17/639,096 patent/US20230032643A1/en active Pending
- 2020-08-28 CN CN202080060956.4A patent/CN114375305A/zh active Pending
-
2022
- 2022-02-15 IL IL290649A patent/IL290649A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022079549A5 (ko) | ||
| JP2022061992A5 (ko) | ||
| JP2010502207A5 (ko) | ||
| JP2020023523A5 (ko) | ||
| RU2012118636A (ru) | Молекула, специфически связывающаяся с rsv | |
| HRP20191277T1 (hr) | Anti-cd26 antitijela i njihove primjene | |
| CA2699834A1 (en) | Improved anti-il-6 receptor antibody | |
| JP2020505927A5 (ko) | ||
| RU2019118359A (ru) | Антитело к cd73 человека | |
| HRP20192160T1 (hr) | Vezujući proteini serumskog albumina | |
| HRP20191409T1 (hr) | Postupci i sredstva za proizvodnju heterodimernih ig-sličnih molekula | |
| JP2020505017A5 (ko) | ||
| JP2017114866A5 (ko) | ||
| JP2018521638A5 (ko) | ||
| FI3484915T3 (fi) | Uusia zikavirusepitooppeihin spesifisesti sitoutuvia vasta-aineita ja niiden käyttöjä | |
| JP2011514139A5 (ko) | ||
| JP2018520654A5 (ko) | ||
| JP2014506790A5 (ko) | ||
| JP2020504101A5 (ko) | ||
| JP2010506596A5 (ko) | ||
| FI2155783T4 (fi) | Lajien välisesti spesifinen cd3-epsilon-sitoutumisdomeeni | |
| JP2020500510A5 (ko) | ||
| FI3683235T3 (fi) | Anti-IL-33-vasta-aineita ja niiden käyttöjä | |
| RU2013141078A (ru) | Одновалентные антигенсвязывающие белки | |
| JP2005120106A5 (ko) |